Here are relevant reports on : medical-research-market
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Medical Coatings Market by Coating Type (Active, Passive), By Material (Polymers, Metals), By Substrate (Metals, Polymers, Ceramics), By Application (Medical Devices, Medical Implants, Medical Equipment & Tools), By Region - Global Forecast to 2031
The medical coatings market is projected to grow from USD 10.92 billion in 2026 to USD 17.42 billion by 2031, at a CAGR of 9.8% during the forecast period. The key players include The medical coatings market is projected to grow from USD 10.92 billion in 2026 to USD 17.42 billion by 2031, at a CAGR of 9.8% during the forecast period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Medical Plastics Market by Type (Standard Plastics, Engineering Plastics, High-performance Plastics), Application (Medical Disposables, Medical Instruments & Devices, Prosthetics & Implants, Drug Delivery, Medical Packaging) - Global Forecast to 2031
The medical plastics market is expected to reach USD 48.77 billion by 2031 from USD 34.77 billion in 2026, recording a CAGR of 7.0% during the forecast period. The report profiles key companies, including BASF (Germany), Celanese Corporation (US), SABIC (Saudi Arabia), Covestro AG (Germany), Syensqo (Belgium), Evonik Industries (Germany), Arkema (France), Lubrizol (US), Ensinger (Germany), and Dow (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
LITHIUM Cobalt Oxide Market Research Report by Application, Type & Region
The growth of the Lithium cobalt oxide market is attributed to the increasing demand for lithium-ion batteries, which are used in a variety of applications, such as electric vehicles, consumer electronics, and energy storage. Lithium cobalt oxide is a key component of lithium-ion batteries, as it provides high energy density and long cycle life. The increasing demand for electric vehicles is a major driver for the growth of the lithium cobalt oxide market. The growth of the electric vehicle market is being driven by government regulations, rising environmental concerns, and declining battery prices.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Direct Conjugated Antibody Market by Application, Research Area, End User and Region - Global Forecast 2030
Direct conjugated antibodies are widely utilized in research and diagnosis, encompassing disciplines like immunology, cancer, and neuroscience. Direct conjugated antibodies are more in demand as a result of the increased prevalence of chronic diseases, rising R&D expenditures, and the requirement for precise diagnostics.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
RNAI Technology Market- by Application (Research, Therapeutics) - Global Forecasts to 2019
The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
US Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] Forecast to 2031
The US Medical Gas and Equipment Market, valued at USD 8.18 million in 2024, stood at USD 8.63 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2031, culminating in a forecasted valuation of USD 11.97 million by the end of the period. The growth of the medical gas and equipment market in US is primarily driven by the rising incidence of respiratory and chronic diseases, including COPD, asthma, cardiovascular disorders, and sleep apnea, as well as a rapidly aging population that requires long-term oxygen therapy and critical care support.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Medical Packaging Market by Material (Polymer, Non-woven Fabric, Paper & Paperboard), Packaging Type (Bags & Pouches, Trays, Boxes), Application (Medical Equipment & Tools, Medical Devices, Implants, IVDs), Packing Type, and Region - Forecast to 2022
The market for medical packaging is projected to grow from USD 35.31 Billion in 2016 to USD 50.55 Billion by 2022, at a compound annual growth rate (CAGR) of 6.29% from 2017 to 2022. The base year considered for the study is 2016 and the market size is projected from 2017 to 2022. The global market for medical packaging is dominated by large players such as Avery Dennison Corporation (U.S.), 3M Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), CCL Industries, Inc. (Canada) , Amcor Limited (Australia), Constantia Flexibles Group GmbH (Austria), Bemis Company (U.S.) , Sonoco Products Company (U.S.) , WestRock Company (U.S.). These players have adopted various strategies to expand their global presence and increase their market share. Mergers & acquisitions, expansions, and new product launches are some of the major strategies adopted by market players to achieve growth in the medical packaging market.
- Published: July 2017
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50